Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | MBX | CLDX | ||
| Company | Dicerna Pharmaceutic | Mbx Biosciences Inc | Celldex Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 64.84 | 37.26 | ||
| High | 38.24 | 66.66 | 38.59 | ||
| Low | 38.21 | 62.99 | 37.23 | ||
| Last | 38.22 | 66.46 | 38.49 | ||
| Change | +0.22 | +2.50 | +0.98 | ||
| Percent Change | +0.58% | +3.91% | +2.60% | ||
| Volume | 5,568,900 | 548,100 | 743,200 | ||
| 20-Day Average Volume | 3,647,665 | 760,960 | 961,980 | ||
| Previous | 38.00 | 63.96 | 37.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 61.03 | 37.14 | ||
| 20-Day Raw Stochastic | 90.72% | 98.59% | 73.81% | ||
| 20-Day Relative Strength | 80.40 | 65.81 | 61.77 | ||
| Weighted Alpha | +35.17 | +163.46 | +60.30 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | +4.55% since 07/23/26 | +8.65% since 07/23/26 | ||
| Low | 37.81 on 12/21/21 | 58.78 on 07/28/26 | 34.74 on 07/24/26 | ||
| High | 38.24 on 12/27/21 | 66.66 on 07/30/26 | 38.59 on 07/30/26 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | +20.40% since 06/30/26 | +3.43% since 06/30/26 | ||
| Low | 37.78 on 12/10/21 | 52.51 on 07/14/26 | 33.37 on 07/22/26 | ||
| High | 38.26 on 12/03/21 | 66.66 on 07/30/26 | 40.30 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | +119.92% since 04/30/26 | +17.05% since 04/30/26 | ||
| Low | 19.06 on 10/06/21 | 28.00 on 06/08/26 | 28.38 on 06/08/26 | ||
| High | 38.26 on 12/03/21 | 66.66 on 07/30/26 | 40.30 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | +80.35% since 01/30/26 | +56.44% since 01/30/26 | ||
| Low | 19.06 on 10/06/21 | 26.14 on 03/30/26 | 22.33 on 02/06/26 | ||
| High | 40.14 on 07/20/21 | 66.66 on 07/30/26 | 40.30 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,044,367 | 2,944,235 | ||
| Shares Outstanding, K | 78,129 | 47,598 | 78,492 | ||
| Annual Sales, $M | 164,310,000 | 0 | 1,550,000 | ||
| Annual Net Income, $M | -112,750,000 | -86,970,000 | -258,760,000 | ||
| Last Qtr Sales, $M | 62,950,000 | 0 | 20,000 | ||
| Last Qtr Income, $M | -17,070,000 | -23,520,000 | -78,690,000 | ||
| 60-Month Beta | 0.80 | 0.16 | 0.90 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | -0.51 on 05/07/26 | -1.18 on 05/07/26 | ||
| Latest Earnings Date | 02/24/22 | 08/06/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||